Clinical Research Directory
Browse clinical research sites, groups, and studies.
Invasive Candidiasis in Critical Care
Sponsor: University Hospital Ostrava
Summary
The combination of acute phase marker monitoring and the "T2Candida" assay (name of the test) will represent an acceleration of the identification of the causative agent of mycotic infection, a significant improvement in the specificity and positive predictive value of this strategy in the diagnosis of invasive candidiasis and candidemia in ICU patients, thereby improving the clinical condition of patients and reducing the cost of specific antifungal therapy.
Key Details
Gender
All
Age Range
12 Months - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2024-04-11
Completion Date
2027-12
Last Updated
2025-06-05
Healthy Volunteers
No
Conditions
Interventions
Invasive candidiasis test
The combination of acute phase marker monitoring and the T2Candida assay will be assessed.
Urine sample collection for future research
Patients will be asked to provide a urine sample for future research (urine biobank).
Locations (2)
University Hospital Ostrava
Ostrava, Moravian-Silesian Region, Czechia
University Hospital Motol
Prague, Czechia